Treatment Shortening of MDR-TB Using Existing and New Drugs

Clinical trial NCT02619994 · COMPLETED

Trial details

NCT number: NCT02619994
Sponsor: Seoul National University Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Tuberculosis, Multidrug-Resistant

Start date: 2016-01-01
Primary completion: 2021-06-01
Enrollment: 214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.